Cronos Group Inc (NASDAQ:CRON) saw a significant decline in short interest in February. As of February 28th, there was short interest totalling 21,174,013 shares, a decline of 9.7% from the February 15th total of 23,460,380 shares. Based on an average daily trading volume, of 14,162,600 shares, the short-interest ratio is currently 1.5 days.

A number of large investors have recently made changes to their positions in CRON. Private Advisor Group LLC bought a new position in Cronos Group in the third quarter valued at approximately $206,000. Stratos Wealth Partners LTD. bought a new position in Cronos Group in the third quarter valued at approximately $116,000. Cambridge Investment Research Advisors Inc. increased its stake in Cronos Group by 173.0% in the third quarter. Cambridge Investment Research Advisors Inc. now owns 34,201 shares of the company’s stock valued at $380,000 after acquiring an additional 21,671 shares during the last quarter. Janney Montgomery Scott LLC bought a new position in Cronos Group in the third quarter valued at approximately $169,000. Finally, Global Financial Private Capital LLC bought a new position in Cronos Group in the third quarter valued at approximately $129,000. 13.51% of the stock is currently owned by institutional investors and hedge funds.

Shares of NASDAQ:CRON opened at $21.14 on Thursday. The company has a market capitalization of $3.99 billion and a P/E ratio of 2,114.00. Cronos Group has a 1 year low of $5.12 and a 1 year high of $25.10.

A number of equities research analysts have recently weighed in on CRON shares. GMP Securities downgraded shares of Cronos Group from a “buy” rating to a “hold” rating in a research report on Tuesday, February 5th. They noted that the move was a valuation call. Jefferies Financial Group initiated coverage on shares of Cronos Group in a research note on Monday, February 25th. They issued an “underperform” rating on the stock. Zacks Investment Research raised shares of Cronos Group from a “strong sell” rating to a “hold” rating in a research note on Monday, February 11th. BMO Capital Markets cut shares of Cronos Group from a “market perform” rating to an “underperform” rating and set a $21.43 price objective on the stock. in a research note on Monday. They noted that the move was a valuation call. Finally, Canaccord Genuity reissued an “average” rating and issued a $9.00 price objective on shares of Cronos Group in a research note on Thursday, November 15th. Three equities research analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $11.05.

ILLEGAL ACTIVITY NOTICE: “Cronos Group Inc (CRON) Sees Large Drop in Short Interest” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2019/03/14/cronos-group-inc-cron-sees-large-drop-in-short-interest.html.

About Cronos Group

Cronos Group Inc, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations “MMPR”. The firm typically invests in companies based in Canada.

Featured Story: What is the price-sales ratio?

Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.